nodes	percent_of_prediction	percent_of_DWPC	metapath
Brotizolam—PTAFR—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.316	0.316	CbGpPWpGaD
Brotizolam—PTAFR—GPCR ligand binding—CXCL11—nasal cavity cancer	0.241	0.241	CbGpPWpGaD
Brotizolam—PTAFR—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.136	0.136	CbGpPWpGaD
Brotizolam—PTAFR—Signaling by GPCR—CXCL11—nasal cavity cancer	0.124	0.124	CbGpPWpGaD
Brotizolam—PTAFR—Signaling Pathways—CXCL11—nasal cavity cancer	0.073	0.073	CbGpPWpGaD
Brotizolam—PTAFR—Immune System—FRS2—nasal cavity cancer	0.0666	0.0666	CbGpPWpGaD
Brotizolam—PTAFR—Signaling Pathways—FRS2—nasal cavity cancer	0.043	0.043	CbGpPWpGaD
